Annual CAPEX
$648.00 K
-$2.25 M-77.66%
December 31, 2024
Summary
- As of March 9, 2025, ARCT annual capital expenditures is $648.00 thousand, with the most recent change of -$2.25 million (-77.66%) on December 31, 2024.
- During the last 3 years, ARCT annual CAPEX has fallen by -$2.76 million (-80.97%).
- ARCT annual CAPEX is now -91.61% below its all-time high of $7.73 million, reached on December 31, 2022.
Performance
ARCT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$0.00
-$80.00 K-100.00%
December 31, 2024
Summary
- As of March 9, 2025, ARCT quarterly capital expenditures is $0.00, with the most recent change of -$80.00 thousand (-100.00%) on December 31, 2024.
- Over the past year, ARCT quarterly CAPEX has dropped by -$328.00 thousand (-100.00%).
- ARCT quarterly CAPEX is now -100.00% below its all-time high of $3.81 million, reached on December 31, 2022.
Performance
ARCT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$648.00 K
-$875.00 K-57.45%
December 31, 2024
Summary
- As of March 9, 2025, ARCT TTM capital expenditures is $648.00 thousand, with the most recent change of -$875.00 thousand (-57.45%) on December 31, 2024.
- Over the past year, ARCT TTM CAPEX has dropped by -$1.78 million (-73.27%).
- ARCT TTM CAPEX is now -91.61% below its all-time high of $7.73 million, reached on December 31, 2022.
Performance
ARCT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ARCT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -77.7% | -100.0% | -73.3% |
| 3 y3 years | -81.0% | -100.0% | -87.1% |
| 5 y5 years | -20.8% | -100.0% | -87.1% |
ARCT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.6% | at low | -100.0% | +100.0% | -91.6% | at low |
| 5 y | 5-year | -91.6% | at low | -100.0% | +100.0% | -91.6% | at low |
| alltime | all time | -91.6% | +162.3% | -100.0% | +100.0% | -91.6% | +318.1% |
Arcturus Therapeutics Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $648.00 K(-77.7%) | $0.00(-100.0%) | $648.00 K(-57.5%) |
| Sep 2024 | - | $80.00 K(-75.6%) | $1.52 M(-37.2%) |
| Jun 2024 | - | $328.00 K(+36.7%) | $2.42 M(-1.1%) |
| Mar 2024 | - | $240.00 K(-72.6%) | $2.45 M(-15.5%) |
| Dec 2023 | $2.90 M(-62.5%) | $875.00 K(-10.8%) | $2.90 M(-50.3%) |
| Sep 2023 | - | $981.00 K(+177.1%) | $5.83 M(-17.1%) |
| Jun 2023 | - | $354.00 K(-48.8%) | $7.04 M(+11.6%) |
| Mar 2023 | - | $691.00 K(-81.8%) | $6.31 M(-18.4%) |
| Dec 2022 | $7.73 M(+126.8%) | $3.81 M(+74.2%) | $7.73 M(+53.4%) |
| Sep 2022 | - | $2.19 M(-678.3%) | $5.04 M(+9.1%) |
| Jun 2022 | - | -$378.00 K(-117.9%) | $4.62 M(-14.5%) |
| Mar 2022 | - | $2.11 M(+88.8%) | $5.40 M(+58.5%) |
| Dec 2021 | $3.41 M(+95.5%) | $1.12 M(-36.7%) | $3.41 M(+14.1%) |
| Sep 2021 | - | $1.77 M(+337.1%) | $2.98 M(+80.6%) |
| Jun 2021 | - | $404.00 K(+242.4%) | $1.65 M(-3.8%) |
| Mar 2021 | - | $118.00 K(-83.1%) | $1.72 M(-1.4%) |
| Dec 2020 | $1.74 M | $697.00 K(+60.6%) | $1.74 M(+28.1%) |
| Sep 2020 | - | $434.00 K(-7.5%) | $1.36 M(+25.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $469.00 K(+230.3%) | $1.08 M(+23.0%) |
| Mar 2020 | - | $142.00 K(-54.9%) | $882.00 K(+7.8%) |
| Dec 2019 | $818.00 K(-44.7%) | $315.00 K(+98.1%) | $818.00 K(+12.4%) |
| Sep 2019 | - | $159.00 K(-40.2%) | $728.00 K(-11.4%) |
| Jun 2019 | - | $266.00 K(+241.0%) | $822.00 K(-31.2%) |
| Mar 2019 | - | $78.00 K(-65.3%) | $1.19 M(-19.2%) |
| Dec 2018 | $1.48 M(+488.8%) | $225.00 K(-11.1%) | $1.48 M(+5.3%) |
| Sep 2018 | - | $253.00 K(-60.3%) | $1.40 M(+13.7%) |
| Jun 2018 | - | $638.00 K(+76.2%) | $1.24 M(+101.8%) |
| Mar 2018 | - | $362.00 K(+139.7%) | $612.00 K(+143.8%) |
| Dec 2017 | $251.00 K(-63.5%) | $151.00 K(+79.8%) | $251.00 K(-66.8%) |
| Sep 2017 | - | $84.00 K(+460.0%) | $756.00 K(+11.3%) |
| Jun 2017 | - | $15.00 K(+1400.0%) | $679.00 K(+2.0%) |
| Mar 2017 | - | $1000.00(-99.8%) | $666.00 K(-3.2%) |
| Dec 2016 | $688.00 K(+178.5%) | $656.00 K(+9271.4%) | $688.00 K(+267.9%) |
| Sep 2016 | - | $7000.00(+250.0%) | $187.00 K(+3.9%) |
| Jun 2016 | - | $2000.00(-91.3%) | $180.00 K(+1.1%) |
| Mar 2016 | - | $23.00 K(-85.2%) | $178.00 K(+14.8%) |
| Dec 2015 | $247.00 K | $155.00 K | $155.00 K |
FAQ
- What is Arcturus Therapeutics Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual CAPEX year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly CAPEX year-on-year change?
- What is Arcturus Therapeutics Holdings TTM capital expenditures?
- What is the all time high TTM CAPEX for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM CAPEX year-on-year change?
What is Arcturus Therapeutics Holdings annual capital expenditures?
The current annual CAPEX of ARCT is $648.00 K
What is the all time high annual CAPEX for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual capital expenditures is $7.73 M
What is Arcturus Therapeutics Holdings annual CAPEX year-on-year change?
Over the past year, ARCT annual capital expenditures has changed by -$2.25 M (-77.66%)
What is Arcturus Therapeutics Holdings quarterly capital expenditures?
The current quarterly CAPEX of ARCT is $0.00
What is the all time high quarterly CAPEX for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly capital expenditures is $3.81 M
What is Arcturus Therapeutics Holdings quarterly CAPEX year-on-year change?
Over the past year, ARCT quarterly capital expenditures has changed by -$328.00 K (-100.00%)
What is Arcturus Therapeutics Holdings TTM capital expenditures?
The current TTM CAPEX of ARCT is $648.00 K
What is the all time high TTM CAPEX for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM capital expenditures is $7.73 M
What is Arcturus Therapeutics Holdings TTM CAPEX year-on-year change?
Over the past year, ARCT TTM capital expenditures has changed by -$1.78 M (-73.27%)